Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04520191 · ClinicalTrials.gov registry record

Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study

A clinical trial, sponsored by University of New Mexico.

Completed
Registry status
309
Enrollment target

NCT04520191 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 309 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04520191 has completed, sponsored by University of New Mexico.

COMPLETED
Registry status
309 participants
Enrollment target

Study Summary

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) OR COVID-19 related Addition: The aim of this addition activity is to track the impact of the COVID-19 epidemic on participants with diabetes and chronic kidney disease (CKD). Investigators have modified the original HBKC Study protocol to expand data currently collected from study participants to include data in the following domains linked to the COVID-19 epidemic: symptoms of COVID-19 disease, access to healthcare, and impact on health related behaviors (such as medication adherence, physical activity, dietary behaviors, smoking, and alcohol use).

Trial Details

FieldValue
Enrollment Target 309 participants
Start Date 2021-01-04
Est. Completion 2024-08-01

Sponsor

University of New Mexico

168 total trials

What the Registry Record Tells You About NCT04520191

The ClinicalTrials.gov registry entry for NCT04520191 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 309 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04520191 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04520191 about?

NCT04520191 is a clinical study titled "Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study". Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) OR COVID-19 related Addition: The aim of this addition activity is to track the impact of the COVID-19 epidemic on participants with diabetes and chronic kidney disease (CKD). Investigators have modified the original HBKC Study proto...

What is the current status of trial NCT04520191?

This trial is currently completed. The enrollment target is 309 participants. The study started on 2021-01-04. Estimated completion is 2024-08-01.

Who is sponsoring clinical trial NCT04520191?

This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.